The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of interruptions in chemotherapy on survival for patients with metastatic or recurrent cervical cancer.
 
Risha Sinha
No Relationships to Disclose
 
Arianna Portmann
No Relationships to Disclose
 
Christopher Walker
No Relationships to Disclose
 
Steven Holloway
No Relationships to Disclose
 
Elizabeth Stock
No Relationships to Disclose
 
David Miller
Consulting or Advisory Role - AADi; Aptitude Health; AstraZeneca; Boxer Capital; Cardinal Health; Clinical Education Alliance; Clinical Education Alliance; Curio Science; Eisai; Eisai Europe; GlaxoSmithKline; IDEOlogy Health; Intellisphere; InVitae; Karyopharm Therapeutics; Merck Sharp & Dohme; Mural Oncology; Prime Education
Research Funding - Advaxis (Inst); Advenchen Laboratories (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Akeso Biopharma (Inst); Aprea AB (Inst); AstraZeneca (Inst); EMD Serono; Immunogen (Inst); Incyte (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Leap Therapeutics; Mateon Therapeutics (Inst); Merck Sharp & Dohme (Inst); Millenium Pharamceuticals (Inst); Novartis (Inst); NVision (Inst); Pfizer (Inst); Regeneron (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst); TRACON Pharma (Inst); US Biotest (Inst); Xenetic Biosciences (Inst)
 
Lesley Conrad
No Relationships to Disclose
 
James Wilder
No Relationships to Disclose
 
Devin Jones
No Relationships to Disclose
 
Jayanthi Lea
Consulting or Advisory Role - AstraZeneca
Research Funding - Merck